141 – 150 of 779
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Foetal and neonatal alloimmune thrombocytopenia – The role of the HLA-DRB3*01:01 allele for HPA-1a-immunisation and foetal/neonatal outcome
- Contribution to journal › Scientific review
-
Mark
Two Prevalent ∼100-kb GYPB Deletions Causative of the GPB-Deficient Blood Group MNS Phenotype S-s-U-in Black Africans
- Contribution to journal › Article
-
Mark
Outcome and characteristics of non-measurable myeloma : A cohort study with population-based data from the Swedish Myeloma Registry
- Contribution to journal › Article
-
Mark
CXCR4 Signaling Has a CXCL12-Independent Essential Role in Murine MLL-AF9-Driven Acute Myeloid Leukemia
- Contribution to journal › Article
-
Mark
SMIM1, carrier of the Vel blood group, is a tail-anchored transmembrane protein and readily forms homodimers in a cell-free system
- Contribution to journal › Article
-
Mark
Excluding myeloma diagnosis using revised thresholds for serum free light chain ratios and M-protein levels
- Contribution to journal › Letter
-
Mark
Search for multiple myeloma risk factors using Mendelian randomization
- Contribution to journal › Article
-
Mark
S100A6 is a critical regulator of hematopoietic stem cells.
(2020) In Leukemia
- Contribution to journal › Article
-
Mark
Health-related quality of life in transplant ineligible newly diagnosed multiple myeloma patients treated with either thalidomide or lenalidomide-based regimen until progression : A prospective, open-label, multicenter, randomized, phase 3 study
- Contribution to journal › Article
-
Mark
Identification of regulators of hematopoietic stem and progenitor cells in vivo in humans using population genetics
(2020) European Human Genetics Virtual Conference
- Contribution to conference › Abstract
